Alice Mariottini

18PUBLICATIONS
35CO-AUTHORS
HaematologyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityOrthoptics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 26, 2026
Should autologous HSCT be a first-line option in highly active MS: YES.

|Oct 20, 2025
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.

Alice Mariottini, Anna Chiara Mazzeo, Edoardo Simonetti

|Sep 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.

Raffaella Greco, Riccardo Saccardi, Marta Ponzano

|Sep 05, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK.

Paolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis

|Jul 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion.

Anna Chiara Mazzeo, Laura Calabresi, Valentina Damato

|Jul 07, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Giacomo Boffa, Angela Genchi, Alice Mariottini

Pageof 3

Frequent Collaborators

4 joint publications

Paolo Antonio Muraro

3 joint publications

Giacomo Boffa

2 joint publications

Olga Ciccarelli

2 joint publications

John A Snowden